Trade

with

AtriCure Inc
(NASDAQ: ATRC)
AdChoices
15.44
+0.19
+1.25%
After Hours :
15.44
0.00
0.00%

Open

14.87

Previous Close

15.25

Volume (Avg)

110.47k (168.86k)

Day's Range

14.87-15.66

52Wk Range

12.22-23.00

Market Cap.

424.16M

Dividend Rate ( Yield )

-

Beta

0.79

Shares Outstanding

27.47M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 81.89M

    • Net Income

    • -11.46M

    • Market Cap.

    • 424.16M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -19.41

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.79

    • Forward P/E

    • -29.41

    • Price/Sales

    • 3.85

    • Price/Book Value

    • 3.16

    • Price/Cash flow

    • -17.27

      • EBITDA

      • -8.86M

      • Return on Capital %

      • -16.99

      • Return on Equity %

      • -21.04

      • Return on Assets %

      • -16.99

      • Book Value/Share

      • 4.89

      • Shares Outstanding

      • 27.47M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 26.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.59

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 29.80

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 8.19

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 71.52

            • 52.83

            • Pre-Tax Margin

            • -19.37

            • 15.96

            • Net Profit Margin

            • -19.41

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 74.10

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -14.00

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -14.00

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.62

              • Current Ratio

              • 5.50

              • 1.97

              • Quick Ratio

              • 4.64

              • 1.16

              • Interest Coverage

              • -33.32

              • 10.47

              • Leverage Ratio

              • 1.16

              • 2.38

              • Book Value/Share

              • 4.89

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -19.80

                • 35.34

                • P/E Ratio 5-Year High

                • -29.54

                • 279.76

                • P/E Ratio 5-Year Low

                • -5.06

                • 148.87

                • Price/Sales Ratio

                • 3.84

                • 3.28

                • Price/Book Value

                • 3.15

                • 4.08

                • Price/Cash Flow Ratio

                • -17.27

                • 16.98

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -21.04

                    (-41.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -16.99

                    (-21.60)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -19.57

                    (-28.90)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 2.85

                  • 2.66

                  • Asset Turnover

                  • 0.88

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -10.89M
                  Operating Margin
                  -13.30
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -17.27
                  Ownership

                  Institutional Ownership

                  88.33%

                  Top 10 Institutions

                  34.34%

                  Mutual Fund Ownership

                  32.50%

                  Float

                  93.99%

                  5% / Insider Ownership

                  5.67%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Polar Capital Healthcare Opps

                  •  

                    711,603

                  • -1.95

                  • 2.59

                  • Fidelity® Select Medical Equip & Systems

                  •  

                    700,000

                  • 0.00

                  • 2.55

                  • RS Small Cap Growth Fund

                  •  

                    555,338

                  • 49.83

                  • 2.02

                  • iShares Russell 2000 (AU)

                  •  

                    429,298

                  • -1.02

                  • 1.62

                  • Vanguard Total Stock Mkt Idx

                  •  

                    362,553

                  • 0.00

                  • 1.32

                  • Wasatch Micro Cap Fund

                  •  

                    351,384

                  • 0.00

                  • 1.28

                  • BlackRock Health Sciences Opps Port

                  •  

                    335,881

                  • 0.00

                  • 1.22

                  • FCP OP MEDICAL BioHealthTrends

                  •  

                    260,824

                  • 0.00

                  • 0.95

                  • Putnam Multi-Cap Growth

                  •  

                    253,576

                  • 0.00

                  • 0.92

                  • Vanguard Extended Market Index Fund

                  •  

                    203,959

                  • 0.54

                  • 0.74

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Adage Capital Partners Gp LLC

                  •  

                    1,750,000

                  • +31.12%

                  • 6.37

                  • Broadfin Capital, LLC

                  •  

                    985,193

                  • +38.27%

                  • 3.59

                  • Cortina Asset Management LLC

                  •  

                    971,773

                  • -2.36%

                  • 3.54

                  • Thomson Horstmann & Bryant, Inc.

                  •  

                    970,740

                  • +6.64%

                  • 3.53

                  • NorthPointe Capital LLC

                  •  

                    847,562

                  • +8.36%

                  • 3.09

                  • RS Investment Management Co. LLC

                  •  

                    843,638

                  • +38.19%

                  • 3.07

                  • Polar Capital LLP

                  •  

                    817,195

                  • 0.00%

                  • 2.97

                  • Fidelity Management and Research Company

                  •  

                    700,000

                  • -12.50%

                  • 2.55

                  • BlackRock Fund Advisors

                  •  

                    681,468

                  • +0.34%

                  • 2.48

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  AtriCure, Inc. was incorporated in the State of Delaware as AtriCure, Inc. on October 31, 2000. It is a medical device company and engaged in developing, manufacturing and selling cardiac surgical ablation systems designed to create ...moreprecise lesions, in cardiac, or heart, tissue for the treatment of atrial fibrillation, and systems for the exclusion of the left atrial appendage. It has two primary product lines for the ablation of cardiac tissue. Its primary product line for the ablation of cardiac tissue is the AtriCure Synergy Ablation System (‘Synergy System’), a bipolar ablation clamp system and related radiofrequency (‘RF’) ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. Additionally, the Company offers the AtriClip Gilli...morenov-Cosgrove Left Atrial Appendage System (‘AtriClip System’), which is designed to safely and effectively exclude the left atrial appendage. Its products are utilized by cardiothoracic surgeons during concomitant open-heart surgical procedures and also during sole-therapy minimally invasive cardiac ablation procedures. During a concomitant open procedure, the surgeon ablates cardiac tissue and/or excludes the left atrial appendage, secondary, or concomitant, to a primary cardiac procedure such as a valve or coronary bypass. Additionally, cardiothoracic surgeons have adopted its products as a treatment alternative for AF patients who may be candidates for sole-therapy minimally invasive surgical procedures. Its Synergy System, which includes its Isolator Synergy clamps, a radiofrequency generator and related switchbox, is cleared by the FDA, for the treatment of patients with persistent and long-standing persistent AF during open-heart concomitant coronary artery bypass grafting and/or valve replacement or repair procedures. In the United States it primarily sells its products to medical centers through its direct sales force. AtriCure Europe, B.V., its wholly-owned subsidiary incorporated and based in the Netherlands, markets and sells its products throughout Europe, the Middle East and Africa, or EMEA, primarily through distributors, while in certain markets, such as Germany and the Benelux region, it sell directly to medical centers. Additionally, it sells its products to other international distributors, mainly in Asia, South America and Canada. The Company’s competitors include Biosense Webster, Inc. (a subsidiary of Johnson & Johnson), St. Jude Medical, Inc., and Medtronic, Inc. Its products are medical devices and are subject to regulation by the FDA, as well as other federal and state regulatory bodies in the United States and comparable authorities in other countries.lessless

                  Key People

                  Michael H. Carrel

                  Director/President/CEO

                  Richard M. Johnston

                  Chairman of the Board/Director

                  Michael D. Hooven

                  Director/Founder

                  Mr. M. Andrew Wade

                  CFO/Chief Accounting Officer/Vice President

                  Dr. Andrew Lux, PhD

                  Senior Executive VP, Divisional

                  • AtriCure Inc

                  • 6217 Centre Park Drive

                  • West Chester, OH 45069

                  • USA.Map

                  • Phone: +1 513 755-4100

                  • Fax: -

                  • atricure.com

                  Incorporated

                  2000

                  Employees

                  320

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: